Skip to main content
Full access
Letters to the Editor
Published Online: 3 October 2008

Disclosure Controversy

I read my August 15 Psychiatric News. An important contribution is Dr. Nada Stotland's column, “From the President,” in which she describes her experience at the annual meeting, without pharmaceutical company support, of the Royal College of Psychiatrists in London.
In the same issue is coverage of APA President-elect Alan Schatzberg, M.D.'s happenings, describing point by point Stanford University's responses to Sen. Charles Grassley's congressional charges and to questions from Psychiatric News. Stanford's removal of Dr. Schatzberg as principal investigator is not reported. I accept the reportage as accurate and clarifying about these events and about relationships our federal statutes encourage.
In my recent posting to APA's Member-to-Member Listserv, I called for Dr. Schatzberg to step aside [as president-elect]. My comment has triggered considerable discussion, as I had intended. If Dr. Schatzberg disclosed these events during the APA election, I missed it and apologize. His responses to Psychiatric News—“I don't relish the publicity” and “I have nothing to hide”—need to be augmented by a statement from him describing these events as he sees them to the membership. With his impending assumption of the presidency, it is still timely.
It is past time that APA begins to move toward self-reliance in its activities. It is clear that others as well as I have been uncomfortable with the symbiotic nature of our relationship with the pharmaceutical industry. Our statement of ethics cautions against doing business with our patients; we also need a statement of ethics about our relationships with patient-related industry. Many actions that are not against the law and some that are sanctioned by the law do not serve well our profession or our patients.
I appreciate and congratulate Dr. Stotland's description of the Royal College's self-financed meeting. I call on her and the president-elect to provide leadership to APA to move to a similar clarification and exploration of self-reliance of the organization and its members.

Footnote

Editor's note: See Dr. Schatzberg's statement on regarding issues arising from the investigation by Sen. Grassley of the pharmaceutical industry's ties to medicine.

Information & Authors

Information

Published In

History

Published online: 3 October 2008
Published in print: October 3, 2008

Authors

Affiliations

Nicholas E. Stratas, M.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share